A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
By G. Giovannoni, G. Comi, S. Cook, K. Rammohan, P. Rieckmann, P. Soelberg Sørensen, P. Vermersch, P. Chang, A. Hamlett, B. Musch and 1 more. New England Journal of Medicine, 2010
900 citations recorded by the source corpus.
Subfields: Hematology, Oncology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/17ae27fedd460bf05ed0b89af766d51bcc54636e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) (2011, background): “Cladribine, an immunosuppressant showing remarkable results from phase II and III studies in RRMS, is not reported to have been tested in EAE (Giovannoni et al., 2010).”